Antiprotozoal Drugs Market Size, Share, and Industry Analysis, By Disease Indication (Malaria, Amoebiasis, Giardiasis, Trichomoniasis, Chagas Disease, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities
   4. Market Trends
4. Key Insights
   1. Prevalence/Incidence of Key Protozoal Diseases, By Key Countries, 2023
   2. Overview: Reimbursement Scenario, By Key Countries/Region
   3. Key Industry Developments: Mergers, Acquisitions, Partnerships, etc.
   4. Pipeline Analysis, By Key Players
   5. New Product Launches, By Key Players
   6. Impact of COVID-19 on the Market
5. Global Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Malaria
      2. Amoebiasis
      3. Giardiasis
      4. Trichomoniasis
      5. Chagas disease
      6. Others
   2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online Pharmacies
   4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Malaria
      2. Amoebiasis
      3. Giardiasis
      4. Trichomoniasis
      5. Chagas disease
      6. Others
   2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online Pharmacies 
   4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
7. Europe Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Malaria
      2. Amoebiasis
      3. Giardiasis
      4. Trichomoniasis
      5. Chagas disease
      6. Others
   2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online Pharmacies 
   4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Malaria
      2. Amoebiasis
      3. Giardiasis
      4. Trichomoniasis
      5. Chagas disease
      6. Others
   2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online Pharmacies
   4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
9. Latin America Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Disease Indication
      1. Malaria
      2. Amoebiasis
      3. Giardiasis
      4. Trichomoniasis
      5. Chagas disease
      6. Others
   2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
   3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores and Retail Pharmacies
      3. Online Pharmacies
   4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America 
10. Middle East & Africa Antiprotozoal Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Disease Indication
       1. Malaria
       2. Amoebiasis
       3. Giardiasis
       4. Trichomoniasis
       5. Chagas disease
       6. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
       1. Oral
       2. Parenteral
       3. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
       1. Hospital Pharmacies
       2. Drug Stores and Retail Pharmacies
       3. Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
       1. GCC
       2. South Africa
       3. Rest of Middle East & Africa 
11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
       1. Lupin
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       2. Novartis AG
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       3. Bayer AG
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       4. GSK plc.
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       5. F. Hoffmann-La Roche Ltd 
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       6. Sanofi
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       7. Cipla
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       8. Sun Pharmaceutical Industries Ltd.
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       9. Pfizer Inc.
          1. Overview
          2. Products
          3. SWOT Analysis
          4. Recent Developments
          5. Strategies
          6. Financials (Based on Availability)
       10. Other Prominent Players